NORTH AMERICA ORTHOPEDIC MARKET FORECAST 2017-2024
KEY FINDINGS
The Asia Pacific orthopedic market is anticipated to grow $35321 million by 2024. The market growth is expected at the CAGR of 6.15% in the forecast period. The base year considered for the market study is 2016. Multiple cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The North America orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The North America orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The North America orthopedic market is further segmented into US, Canada, and rest of North America. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the growth of the market are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
REGIONAL INSIGHTS
North America holds the largest market share of 43.35% in 2016 in the global orthopedic market. The driving factors responsible for the growth of North America region in the orthopedic market are rising demand for the outpatient techniques, growing elderly population in the North American region. US region is the key influencer of the North America orthopedic market. Increase in the prevalence of arthritis due to rising elderly population in the US region. In the United States, around 56% people are suffering from musculoskeletal diseases which are the largest as compared to other chronic diseases such as respiratory 29%, circulatory 32%, diabetes 14% and cancer 10%.
The Asia Pacific orthopedic market is anticipated to grow $35321 million by 2024. The market growth is expected at the CAGR of 6.15% in the forecast period. The base year considered for the market study is 2016. Multiple cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The North America orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The North America orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The North America orthopedic market is further segmented into US, Canada, and rest of North America. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the growth of the market are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
REGIONAL INSIGHTS
North America holds the largest market share of 43.35% in 2016 in the global orthopedic market. The driving factors responsible for the growth of North America region in the orthopedic market are rising demand for the outpatient techniques, growing elderly population in the North American region. US region is the key influencer of the North America orthopedic market. Increase in the prevalence of arthritis due to rising elderly population in the US region. In the United States, around 56% people are suffering from musculoskeletal diseases which are the largest as compared to other chronic diseases such as respiratory 29%, circulatory 32%, diabetes 14% and cancer 10%.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. NORTH AMERICA BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. NORTH AMERICAORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE- INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. NORTH AMERICA ANALYSIS
7.1. NORTH AMERICA ORTHOPEDIC MARKET
7.1.1. UNITED STATES ORTHOPEDIC MARKET
7.1.2. CANADA ORTHOPEDIC MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 NORTH AMERICAORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 NORTH AMERICAORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 NORTH AMERICAORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 NORTH AMERICAORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 NORTH AMERICAORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 NORTH AMERICAORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 NORTH AMERICAORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 NORTH AMERICAORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 NORTH AMERICAORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 NORTH AMERICAORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 NORTH AMERICAORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 NORTH AMERICAORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY NORTH AMERICA 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY NORTH AMERICA 2017–2024($ MILLION)
TABLE 20 NORTH AMERICA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURES LIST
FIGURE 1 NORTH AMERICA ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 3 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 4 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 5 GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 6 NORTH AMERICAORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 7 NORTH AMERICAORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 8 NORTH AMERICAORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 9NORTH AMERICAORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 10 NORTH AMERICAORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 11NORTH AMERICAORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 12NORTH AMERICAORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 13NORTH AMERICAORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 14NORTH AMERICAORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 15NORTH AMERICAORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 16NORTH AMERICAORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 17NORTH AMERICA ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 18NORTH AMERICA VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 19 NORTH-AMERICA VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY REGION, 2017–2024($ MILLION)
FIGURE 20NORTH AMERICA VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY NORTH AMERICA 2017–2024($ MILLION)
FIGURE 21NORTH AMERICA ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 22 NORTH AMERICA ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024(% SHARE)
FIGURE 23 HEALTHCARE EXPENDITURE IN THE U.S. 2014-2025 (% OF GDP)
FIGURE 24 UNITED STATES (U.S.) ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 25 PERSON AGED ABOVE 65 YEARS EXTRAPOLATED 2013-2040 (MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. NORTH AMERICA BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. NORTH AMERICAORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE- INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. NORTH AMERICA ANALYSIS
7.1. NORTH AMERICA ORTHOPEDIC MARKET
7.1.1. UNITED STATES ORTHOPEDIC MARKET
7.1.2. CANADA ORTHOPEDIC MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 NORTH AMERICAORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 NORTH AMERICAORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 NORTH AMERICAORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 NORTH AMERICAORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 NORTH AMERICAORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 NORTH AMERICAORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 NORTH AMERICAORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 NORTH AMERICAORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 NORTH AMERICAORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 NORTH AMERICAORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 NORTH AMERICAORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 NORTH AMERICAORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY NORTH AMERICA 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY NORTH AMERICA 2017–2024($ MILLION)
TABLE 20 NORTH AMERICA ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURES LIST
FIGURE 1 NORTH AMERICA ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 3 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 4 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 5 GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 6 NORTH AMERICAORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 7 NORTH AMERICAORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 8 NORTH AMERICAORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 9NORTH AMERICAORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 10 NORTH AMERICAORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 11NORTH AMERICAORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 12NORTH AMERICAORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 13NORTH AMERICAORTHOPEDIC MARKET BY COMPUTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 14NORTH AMERICAORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 15NORTH AMERICAORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 16NORTH AMERICAORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 17NORTH AMERICA ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 18NORTH AMERICA VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 19 NORTH-AMERICA VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY REGION, 2017–2024($ MILLION)
FIGURE 20NORTH AMERICA VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY NORTH AMERICA 2017–2024($ MILLION)
FIGURE 21NORTH AMERICA ORTHOPAEDICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 22 NORTH AMERICA ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024(% SHARE)
FIGURE 23 HEALTHCARE EXPENDITURE IN THE U.S. 2014-2025 (% OF GDP)
FIGURE 24 UNITED STATES (U.S.) ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 25 PERSON AGED ABOVE 65 YEARS EXTRAPOLATED 2013-2040 (MILLION)
